Isogenica Limited Enters into Research and License Agreement with Wyeth

CAMBRIDGE, England,1st June 2007: Isogenica Ltd, today announced that it has entered into a research and license agreement with Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE).

MORE ON THIS TOPIC